What would a nuanced, risk-based, modernised regulatory framework for digital health need to encompass?  What needs to be retained and what changed to best support an environment that promotes patients' access to new services, facilitates new products and services becoming available, while enhancing overall safety and oversight?  

Join the ABHI and Taylor Wessing for a lively two-part discussion with an expert panel that will explore these and other pressing questions.  Our panellists will share their specific business and regulatory insight into the opportunities facing companies and investors in digital health and AI in the UK.  We anticipate this being a lively discussion that will consider current examples of international best practice as well as ideas and experience from the audience.  

Our expert panel: 

• Charles Lowe, Chief Executive, Digital Health and Care Alliance
• Richard A. Vincins, VP Global Regulatory Affairs, Oriel STAT A MATRIX – A Validant Company
• Alison Dennis, Head of International Life Sciences & Healthcare, Taylor Wessing
• Steve Lee, Director, Diagnostics Regulation, ABHI
  
  

We hope you can join us for what promises to be an engaging conversation at a crucial time for the digital health industry.  

If you are unable to attend, please register to receive the recording